Kaneez Fatima, Zainab Jamil, Samar Faheem, Alishba Adnan, Syed Sarmad Javaid, Hafsa Naeem, Neha Mohiuddin, Anosha Sajid, Sidhant Ochani
OBJECTIVE: Polycystic Ovary Syndrome is the most prevalent hormonal disorder in females. Over the years, metformin (MET) has become the first-line choice of treatment; however, due to its gastrointestinal side effects, a more recent drug, myo-inositol (MI), has been introduced. We aim to conduct a systematic review and meta-analysis to compare the effects of MET and MI on hormonal and metabolic parameters. MATERIALS AND METHODS: Authors extensively searched PubMed, Scopus, Cochrane Library, Google Scholar, and Web of Science for randomized clinical trials (RCTs) until August 2021...
May 6, 2023: Irish Journal of Medical Science